Insider Trading Alert - Armstrong World Industries And 4 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Sept. 13, 2013, 141 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $99.99 to $478,779,119.37.

Highlighted Stocks Traded by Insiders:

Armstrong World Industries (AWI) - FREE Research Report

Armstrong World Industries, Inc. Asbestos Personal Injury Settlement Trust who is 10% Owner at Armstrong World Industries sold 9.3 million shares at $51.41 on Sept. 13, 2013. Following this transaction, the 10% Owner owned 16.0 million shares meaning that the stake was reduced by 36.72% with the 9.3 million share transaction.

TPG Advisors VI, Inc. who is 10% Owner at Armstrong World Industries sold 2.7 million shares at $51.41 on Sept. 13, 2013. Following this transaction, the 10% Owner owned 3.4 million shares meaning that the stake was reduced by 44.79% with the 2.7 million share transaction.

The shares most recently traded at $53.35, up $1.94, or 3.64% since the insider transaction. Historical insider transactions for Armstrong World Industries go as follows:

  • 24-Week # shares sold: 5,100

The average volume for Armstrong World Industries has been 350,600 shares per day over the past 30 days. Armstrong World Industries has a market cap of $3.1 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 3.45% year to date as of the close of trading on Friday.

Armstrong World Industries, Inc. engages in the design, manufacture, and sale of flooring products and ceiling systems worldwide. The company has a P/E ratio of 27.1. Currently there are 3 analysts that rate Armstrong World Industries a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AWI - FREE

TheStreet Quant Ratings rates Armstrong World Industries as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, poor profit margins and weak operating cash flow. Get the full Armstrong World Industries Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

BroadSoft (BSFT) - FREE Research Report

Hoffpauir Scott D. who is Chief Technology Officer at BroadSoft sold 60,000 shares at $36.00 on Sept. 13, 2013. Following this transaction, the Chief Technology Officer owned 135,112 shares meaning that the stake was reduced by 30.75% with the 60,000 share transaction.

The shares most recently traded at $36.92, up $0.92, or 2.49% since the insider transaction. Historical insider transactions for BroadSoft go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 10,722
  • 12-Week # shares bought: 1,500
  • 12-Week # shares sold: 16,873
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 22,276

The average volume for BroadSoft has been 353,900 shares per day over the past 30 days. BroadSoft has a market cap of $1.0 billion and is part of the technology sector and computer software & services industry. Shares are up 1.95% year to date as of the close of trading on Friday.

2003 Revenue $5.4 million 2006 Revenue $36.8 million (Source: INC Magazine) 2009 Revenue $100 million (Source: Paul Bowen 9/4/08). The company has a P/E ratio of 370.4. Currently there are 4 analysts that rate BroadSoft a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSFT - FREE

TheStreet Quant Ratings rates BroadSoft as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full BroadSoft Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Geo Group (GEO) - FREE Research Report

Hurley John who is President - U.S. Corrections at Geo Group sold 19,679 shares at $32.55 on Sept. 13, 2013. Following this transaction, the President - U.S. Corrections owned 34,143 shares meaning that the stake was reduced by 36.56% with the 19,679 share transaction.

The shares most recently traded at $32.12, down $0.43, or 1.32% since the insider transaction. Historical insider transactions for Geo Group go as follows:

  • 4-Week # shares sold: 6,534
  • 12-Week # shares sold: 32,198
  • 24-Week # shares sold: 32,198

The average volume for Geo Group has been 574,900 shares per day over the past 30 days. Geo Group has a market cap of $2.3 billion and is part of the services sector and diversified services industry. Shares are up 13.4% year to date as of the close of trading on Friday.

The GEO Group, Inc. provides government-outsourced services specializing in the management of correctional, detention, and re-entry facilities, and the provision of community based services and youth services in the United States, Australia, South Africa, the United Kingdom, and Canada. The stock currently has a dividend yield of 6.14%. The company has a P/E ratio of 12.5. Currently there are 5 analysts that rate Geo Group a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GEO - FREE

TheStreet Quant Ratings rates Geo Group as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, notable return on equity, reasonable valuation levels and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Geo Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Pacira Pharmaceuticals (PCRX) - FREE Research Report

Kronenfeld Mark A. who is Director at Pacira Pharmaceuticals bought 1,000 shares at $37.01 on Sept. 13, 2013. Following this transaction, the Director owned 1,000 shares meaning that the stake was reduced by 100% with the 1,000 share transaction.

The shares most recently traded at $40.05, up $3.04, or 7.59% since the insider transaction. Historical insider transactions for Pacira Pharmaceuticals go as follows:

  • 24-Week # shares bought: 853
  • 24-Week # shares sold: 22,746

The average volume for Pacira Pharmaceuticals has been 356,000 shares per day over the past 30 days. Pacira Pharmaceuticals has a market cap of $1.3 billion and is part of the health care sector and drugs industry. Shares are up 118.71% year to date as of the close of trading on Friday.

Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers worldwide. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. Currently there are 4 analysts that rate Pacira Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on PCRX - FREE

TheStreet Quant Ratings rates Pacira Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and generally high debt management risk. Get the full Pacira Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Cognizant Technology Solutions Corporation (CTSH) - FREE Research Report

Dsouza Francisco who is Chief Executive Officer at Cognizant Technology Solutions Corporation sold 24,700 shares at $80.00 on Sept. 13, 2013. Following this transaction, the Chief Executive Officer owned 109,934 shares meaning that the stake was reduced by 18.35% with the 24,700 share transaction.

McLoughlin Karen who is Chief Financial Officer at Cognizant Technology Solutions Corporation sold 1,200 shares at $80.00 on Sept. 13, 2013. Following this transaction, the Chief Financial Officer owned 9,296 shares meaning that the stake was reduced by 11.43% with the 1,200 share transaction.

The shares most recently traded at $80.74, up $0.74, or 0.92% since the insider transaction. Historical insider transactions for Cognizant Technology Solutions Corporation go as follows:

  • 4-Week # shares sold: 64,836
  • 12-Week # shares bought: 7,500
  • 12-Week # shares sold: 67,889
  • 24-Week # shares bought: 7,500
  • 24-Week # shares sold: 70,284

The average volume for Cognizant Technology Solutions Corporation has been 2.6 million shares per day over the past 30 days. Cognizant Technology Solutions Corporation has a market cap of $23.8 billion and is part of the technology sector and computer software & services industry. Shares are up 6.67% year to date as of the close of trading on Friday.

Provide application outsourcing services and enterprise consulting solutions Tier: 3. The company has a P/E ratio of 21.0. Currently there are 15 analysts that rate Cognizant Technology Solutions Corporation a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CTSH - FREE

TheStreet Quant Ratings rates Cognizant Technology Solutions Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Cognizant Technology Solutions Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens